PKB-mediated Thr649 phosphorylation of AS160/TBC1D4 regulates the R-wave amplitude in the heart

PLoS ONE

Volumn 10, Issue 4, 2015, Pages

  Quan, Chao ^a   Xie, Bingxian ^a   Wang, Hong Yu ^a   Chen, Shuai ^a  

^a NANJING UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN; INSULIN; PROTEIN AS160; PROTEIN KINASE B; PROTEIN TBC1D1; THREONINE; TROPONIN T; UNCLASSIFIED DRUG; CD36 ANTIGEN; GLUCOSE TRANSPORTER 4; SLC2A4 PROTEIN, MOUSE; TBC1D1 PROTEIN, MOUSE; TBC1D4 PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING SITE; CONTROLLED STUDY; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; FEMALE; FRACTION SHORTENING; GENE TARGETING; GENOTYPE; HEART ATRIUM; HEART EJECTION FRACTION; HEART ELECTROPHYSIOLOGY; HEART FUNCTION; HEART INFARCTION; HEART VENTRICLE; IN VIVO STUDY; JUVENILE ANIMAL; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; R WAVE; TISSUE LEVEL; WILD TYPE; ANIMAL; CARDIAC MUSCLE; DRUG EFFECTS; ELECTROCARDIOGRAPHY; GENE EXPRESSION REGULATION; GENETICS; HEART MUSCLE CONDUCTION SYSTEM; METABOLISM; MUTATION; PATHOLOGY; PHOSPHORYLATION; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE;

MUS;

ALANINE; ANIMALS; ANTIGENS, CD36; ELECTROCARDIOGRAPHY; FEMALE; GENE EXPRESSION REGULATION; GENE KNOCK-IN TECHNIQUES; GLUCOSE TRANSPORTER TYPE 4; GTPASE-ACTIVATING PROTEINS; HEART CONDUCTION SYSTEM; INSULIN; MALE; MICE; MICE, TRANSGENIC; MUTATION; MYOCARDIAL INFARCTION; MYOCARDIUM; PHOSPHORYLATION; PROTEIN TRANSPORT; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; THREONINE;

EID: 84928656678     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0124491     Document Type: Article

References (24)

1. Muniyappa R, Montagnani M, Koh KK, Quon MJ. Cardiovascular actions of insulin. Endocrine reviews 2007; 28: 463-491. PMID: 17525361
2. Malmberg K, Ryden L, Hamsten A, Herlitz J, Waldenstrom A, Wedel H. Effects of insulin treatment on cause-specific one-year mortality and morbidity in diabetic patients with acute myocardial infarction. DIGAMI Study Group. Diabetes Insulin-Glucose in Acute Myocardial Infarction. European heart journal 1996; 17: 1337-1344. PMID: 8880018
3. Belke DD, Betuing S, Tuttle MJ, Graveleau C, Young ME, Pham M, et al. Insulin signaling coordinately regulates cardiac size, metabolism, and contractile protein isoform expression. The Journal of clinical investigation 2002; 109: 629-639. PMID: 11877471
4. Sena S, Hu P, Zhang D, Wang X, Wayment B, Olsen C, et al. Impaired insulin signaling accelerates cardiac mitochondrial dysfunction after myocardial infarction. Journal of molecular and cellular cardiology 2009; 46: 910-918. doi: 10.1016/j.yjmcc.2009.02.014 PMID: 19249310
5. DeBosch B, Sambandam N, Weinheimer C, Courtois M, Muslin AJ. Akt2 regulates cardiac metabolism and cardiomyocyte survival. The Journal of biological chemistry 2006; 281: 32841-32851. PMID: 16950770
6. Mora A, Davies AM, Bertrand L, Sharif I, Budas GR, Jovanovic S, et al. Deficiency of PDK1 in cardiac muscle results in heart failure and increased sensitivity to hypoxia. The EMBO journal 2003; 22: 4666-4676. PMID: 12970179
7. Laustsen PG, Russell SJ, Cui L, Entingh-Pearsall A, Holzenberger M, Liao R, et al. Essential role of insulin and insulin-like growth factor 1 receptor signaling in cardiac development and function. Molecular and cellular biology 2007; 27: 1649-1664. PMID: 17189427
8. DeBosch B, Treskov I, Lupu TS, Weinheimer C, Kovacs A, Courtois M, et al. Akt1 is required for physiological cardiac growth. Circulation 2006; 113: 2097-2104. PMID: 16636172
9. Chang Z, Zhang Q, Feng Q, Xu J, Teng T, Luan Q, et al. Deletion of Akt1 causes heart defects and abnormal cardiomyocyte proliferation. Developmental biology 2010; 347: 384-391. doi: 10.1016/j.ydbio.2010.08.033 PMID: 20816796
10. Sano H, Kane S, Sano E, Miinea CP, Asara JM, Lane WS, et al. Insulin-stimulated phosphorylation of a Rab GTPase-activating protein regulates GLUT4 translocation. The Journal of biological chemistry 2003; 278: 14599-14602. PMID: 12637568
11. Chen S, Murphy J, Toth R, Campbell DG, Morrice NA, MacKintosh C. Complementary regulation of TBC1D1 and AS160 by growth factors, insulin and AMPK activators. The Biochemical journal 2008; 409: 449-459. PMID: 17995453
12. Roach WG, Chavez JA, Miinea CP, Lienhard GE. Substrate specificity and effect on GLUT4 translocation of the Rab GTPase-activating protein Tbc1d1. The Biochemical journal 2007; 403: 353-358. PMID: 17274760
13. Samovski D, Su X, Xu Y, Abumrad NA, Stahl PD. Insulin and AMPK regulate FA translocase/CD36 plasma membrane recruitment in cardiomyocytes via Rab GAP AS160 and Rab8a Rab GTPase. Journal of lipid research 2012; 53: 709-717. doi: 10.1194/jlr.M023424 PMID: 22315395
14. Kim HY, Choi HJ, Lim JS, Park EJ, Jung HJ, Lee YJ, et al. Emerging role of Akt substrate protein AS160 in the regulation of AQP2 translocation. American journal of physiology Renal physiology 2011; 301: F151-161. doi: 10.1152/ajprenal.00519.2010 PMID: 21511697
15. Liang X, Butterworth MB, Peters KW, Frizzell RA. AS160 modulates aldosterone-stimulated epithelial sodium channel forward trafficking. Molecular biology of the cell 2010; 21: 2024-2033. doi: 10.1091/mbc.E10-01-0042 PMID: 20410134
16. Comellas AP, Kelly AM, Trejo HE, Briva A, Lee J, Sznajder JI, et al. Insulin regulates alveolar epithelial function by inducing Na+/K+-ATPase translocation to the plasma membrane in a process mediated by the action of Akt. Journal of cell science 2010; 123: 1343-1351. doi: 10.1242/jcs.066464 PMID: 20332111
17. Ramm G, Larance M, Guilhaus M, James DE. A role for 14-3-3 in insulin-stimulated GLUT4 translocation through its interaction with the RabGAP AS160. The Journal of biological chemistry 2006; 281: 29174-29180. PMID: 16880201
18. Geraghty KM, Chen S, Harthill JE, Ibrahim AF, Toth R, Morrice NA, et al. Regulation of multisite phosphorylation and 14-3-3 binding of AS160 in response to IGF-1, EGF, PMA and AICAR. The Biochemical journal 2007; 407: 231-241. PMID: 17617058
19. Chen S, Wasserman DH, MacKintosh C, Sakamoto K. Mice with AS160/TBC1D4-Thr649Ala knockin mutation are glucose intolerant with reduced insulin sensitivity and altered GLUT4 trafficking. Cell metabolism 2011; 13: 68-79. doi: 10.1016/j.cmet.2010.12.005 PMID: 21195350
20. Ducommun S, Wang HY, Sakamoto K, MacKintosh C, Chen S. Thr649Ala-AS160 knock-in mutation does not impair contraction/AICAR-induced glucose transport in mouse muscle. American journal of physiology Endocrinology and metabolism 2012; 302: E1036-1043. doi: 10.1152/ajpendo.00379.2011 PMID: 22318952
21. Di R, Wu X, Chang Z, Zhao X, Feng Q, Lu S, et al. S6K inhibition renders cardiac protection against myocardial infarction through PDK1 phosphorylation of Akt. The Biochemical journal 2012; 441: 199-207. doi: 10.1042/BJ20110033 PMID: 21906027
22. Wang HY, Ducommun S, Quan C, Xie B, Li M, Wasserman DH, et al. AS160 deficiency causes wholebody insulin resistance via composite effects in multiple tissues. The Biochemical journal 2013; 449: 479-489. doi: 10.1042/BJ20120702 PMID: 23078342
23. Mazzaro Cdo L, Costa Fde A, Bombig MT, Luna Filho B, Paola AA, Carvalho AC, et al. Ventricular mass and electrocardiographic criteria of hypertrophy: evaluation of new score. Arquivos brasileiros de cardiologia 2008; 90: 227-231. PMID: 18516381
24. von Bibra H, St John Sutton M. Impact of diabetes on postinfarction heart failure and left ventricular remodeling. Current heart failure reports 2011; 8: 242-251. doi: 10.1007/s11897-011-0070-8 PMID: 21842146